1. Home
  2. FKWL vs BYSI Comparison

FKWL vs BYSI Comparison

Compare FKWL & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

N/A

Current Price

$2.43

Market Cap

27.0M

Sector

Utilities

ML Signal

N/A

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.78

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FKWL
BYSI
Founded
1981
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.0M
31.4M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
FKWL
BYSI
Price
$2.43
$0.78
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
10.1K
★ 80.2K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
★ 1.10%
N/A
EPS Growth
★ 94.12
N/A
EPS
N/A
N/A
Revenue
★ $46,086,901.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 49.65
N/A
52 Week Low
$2.21
$0.57
52 Week High
$5.48
$2.44

Technical Indicators

Market Signals
Indicator
FKWL
BYSI
Relative Strength Index (RSI) 49.01 47.65
Support Level $2.21 $0.67
Resistance Level $2.48 $0.80
Average True Range (ATR) 0.06 0.05
MACD -0.00 0.02
Stochastic Oscillator 40.00 69.43

Price Performance

Historical Comparison
FKWL
BYSI

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: